NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory9 Jul 2026
Indo Us Biotech Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Indo Us Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming no securities were received for dematerialization up to June 30, 2026.
NSEDisclosure under SEBI Takeover RegulationsRegulatory9 Jul 2026
Housing & Urban Development Corporation Limited
Disclosure under SEBI Takeover Regulations
Housing & Urban Development Corporation Limited has submitted a disclosure under SEBI Takeover Regulations, furnishing information on substantial acquisition of shares and takeovers for the financial year ended 31st March 2026, as required by Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NSEGeneral Updates▲ PositiveRegulatory9 Jul 2026
Piramal Pharma Limited
General Updates
Piramal Pharma Limited has successfully closed a US FDA inspection at its manufacturing facility in Sellersville, USA, with the issuance of an Establishment Inspection Report (EIR).
NSEAction(s) initiated or orders passedRegulatory9 Jul 2026
Tata Teleservices (Maharashtra) Limited
Action(s) initiated or orders passed
Tata Teleservices (Maharashtra) Limited has received a penalty notice from the Brihanmumbai Municipal Corporation for non-maintenance of a utility chamber on municipal road, with a penalty of Rs. 50,000.
NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory9 Jul 2026
Orient Bell Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Orient Bell Limited has issued a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the compliance of dematerialization of shares for the quarter ended June 30, 2026.
NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory9 Jul 2026
ASK Automotive Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASK Automotive Limited has issued a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended June 30, 2026.
NSEUpdatesRegulatory9 Jul 2026
Onesource Specialty Pharma Limited
Updates
OneSource Specialty Pharma Limited has clarified that the delay in commercial supplies of Semaglutide by Dr. Reddy's Laboratories (DRL) will not have a material impact on their operations, citing sufficient demand from other customers and upcoming capacity additions.
NSEDisclosure under SEBI Takeover RegulationsRegulatory9 Jul 2026
Ksolves India Limited
Disclosure under SEBI Takeover Regulations
Ksolves India Limited has submitted a declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, stating that they have not created or invoked any encumbrance on the equity shares of the company held by them during the financial year ended 31st March 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▼ NegativeRegulatory9 Jul 2026
Dr. Reddy's Laboratories Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Dr. Reddy's Laboratories Limited has informed the Exchange about an issue with certain batches of semaglutide due to an active pharmaceutical ingredient (API) issue, which will delay commercial supplies until the issue is resolved. The company is investigating the root cause and taking measures to ensure product quality.
NSESpurt in VolumeRegulatory9 Jul 2026
SG Mart Limited
Spurt in Volume
SG Mart Limited has responded to a query from the National Stock Exchange of India Limited regarding a significant increase in trading volume. The company assured the exchange that all necessary information and announcements have been disclosed as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and will continue to do so as required.
NSEGeneral UpdatesRegulatory9 Jul 2026
Dr. Reddy's Laboratories Limited
General Updates
Dr. Reddy's Laboratories Limited has announced that certain batches of semaglutide were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the product, leading to commercial supply delays. The company is investigating the root cause and taking measures to ensure product quality. There is no impact on patient safety or existing regulatory filings.
NSEStrikes/Lockouts/DisturbancesRegulatory9 Jul 2026
Antony Waste Handling Cell Limited
Strikes/Lockouts/Disturbances
Antony Waste Handling Cell Limited has informed the Exchange about strikes/lockouts/disturbances at its Waste to Energy facility at Pimpri Chinchwad, Pune, Maharashtra, due to a natural calamity triggered by continuous and exceptionally heavy rainfall.
NSECredit Rating- OthersRegulatory8 Jul 2026
Swan Defence and Heavy Industries Limited
Credit Rating- Others
Swan Defence and Heavy Industries Limited has informed the Exchange about the withdrawal of credit rating assigned to Bank Facilities of Reliance Naval and Engineering Limited by Brickwork Ratings India Private Limited.
NSESpurt in VolumeRegulatory8 Jul 2026
Vaibhav Global Limited
Spurt in Volume
Vaibhav Global Limited has responded to the National Stock Exchange's query regarding a spurt in volume in the company's shares, stating that the increase is due to market conditions and not under their control.
NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory8 Jul 2026
Themis Medicare Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Themis Medicare Limited has informed the Exchange about Certificate under 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.
NSESpurt in VolumeRegulatory8 Jul 2026
D. P. Abhushan Limited
Spurt in Volume
D. P. Abhushan Limited has experienced a significant increase in trading volume, prompting the exchange to contact the company for clarification.
NSESpurt in VolumeRegulatory8 Jul 2026
SG Mart Limited
Spurt in Volume
SG Mart Limited has observed a significant increase in volume, prompting the NSE to write to the company for a response.
NSESpurt in VolumeRegulatory8 Jul 2026
Vaibhav Global Limited
Spurt in Volume
Vaibhav Global Limited has seen a significant increase in trading volume, prompting the exchange to seek clarification from the company.
NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory8 Jul 2026
Kilitch Drugs (India) Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Kilitch Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.
NSEUpdatesRegulatory8 Jul 2026
IVP Limited
Updates
IVP Limited has filed an appeal against the order passed by the Estate Officer, Mumbai Port Authority, and the court has stayed the implementation of the order until the final disposal of the appeal.